Bridge to Life logo

Bridge to Life

Develops organ transplantation technologies aimed at making hypothermic oxygenated perfusion standard in liver care.

Deep Tech
Organ Perfusion
Total Raised
$110M
Headquarters
San Francisco, CA

Overview

Bridge to Life is focused on organ transplant care, with a stated goal of making hypothermic oxygenated perfusion the standard of care in liver transplantation and potentially beyond. Its market includes transplant programs and clinical teams seeking improved organ preservation and perfusion approaches. The company raised $110 million in an undisclosed round announced on Aug. 12, 2026, representing its total disclosed funding in the provided context. As no AI technology is described, the business is best categorized as deep tech medical infrastructure rather than an AI company.

Funding History

1 round · Aug 2026
$110M
Total Raised
1
Cumulative: $110M

Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

Investors not disclosed
Source

Frequently Asked Questions

How much funding does AI Funding track for Bridge to Life?
AI Funding tracks $110M for Bridge to Life across 1 funding round in this database.
What does Bridge to Life do?
Bridge to Life is focused on organ transplant care, with a stated goal of making hypothermic oxygenated perfusion the standard of care in liver transplantation and potentially beyond. Its market includes transplant programs and clinical teams seeking improved organ preservation and perfusion approaches. The company raised $110 million in an undisclosed round announced on Aug. 12, 2026, representing its total disclosed funding in the provided context. As no AI technology is described, the business is best categorized as deep tech medical infrastructure rather than an AI company.
Where is Bridge to Life headquartered?
Bridge to Life is headquartered in San Francisco, CA.